4
Changes in Ownership
LEXICON PHARMACEUTICALS, INC. Filed Acc 0001127602-23-007932
VP, Chief Commercial Officer gave up 11,813 shares (to pay taxes)
- VP, Chief Commercial Officer acquired 43,082 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Seth Kiernan · VP, Chief Commercial Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-02-28 | Exercise or conversion : show line 1 in the form | +14,833 | 36,700 | D | ||
| 2023-02-28 | Exercise or conversion : show line 2 in the form | +5,286 | 41,986 | D | ||
| 2023-02-28 | Exercise or conversion : show line 3 in the form | +22,963 | 64,949 | D | ||
| 2023-02-28 | Shares withheld for taxes : show line 4 in the form | −11,813 | $2.17 | $25,634 | 53,136 | D |
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-02-28 | Exercise or conversion : show line 5 in the form Restricted Stock Units | −14,833 | 0 | D |
| 2023-02-28 | Exercise or conversion : show line 6 in the form Restricted Stock Units | −5,286 | 5,287 | D |
| 2023-02-28 | Exercise or conversion : show line 7 in the form Restricted Stock Units | −22,963 | 45,927 | D |
Loading xslF345X03/form4.xml…